| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232262A2 Recombinant gelatin in vaccines |
| 08/21/2002 | EP1232258A1 Colon tumour-associated antigens |
| 08/21/2002 | EP1232249A1 Duck pneumovirus and corresponding vaccines |
| 08/21/2002 | EP1232248A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 08/21/2002 | EP1232186A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 08/21/2002 | EP1232185A2 Methods of inhibiting metastasis |
| 08/21/2002 | EP1232181A2 Recombinant gelatins |
| 08/21/2002 | EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression |
| 08/21/2002 | EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 08/21/2002 | EP1232168A2 Synthetic lipid-a analogs and uses thereof |
| 08/21/2002 | EP1232167A1 Synthetic oligomannosides, preparation and uses thereof |
| 08/21/2002 | EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties |
| 08/21/2002 | EP1231937A2 Tr3-specific binding agents and methods for their use |
| 08/21/2002 | EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 08/21/2002 | EP1231926A2 New complex, and methods for its production and use |
| 08/21/2002 | EP1231910A2 Inhibitors of endo-exonuclease activity such as pentamidine for treating cancer |
| 08/21/2002 | EP1231840A1 Anti-angiogenic cellular agent for cancer therapy |
| 08/21/2002 | EP0980251B1 Tissue factor for influencing blood vessel formation |
| 08/21/2002 | EP0771192B1 Use of anti-vegf agents in the treatment of endometriosis |
| 08/21/2002 | EP0567577B1 Nucleotide sequences coding for the murine adrenergenic beta 3 receptor and applications thereof |
| 08/21/2002 | CN1365286A Method for treating chronic HBV infection |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1364644A Immuno liposome therapeutic hepatitis B vaccine and its preparing method |
| 08/21/2002 | CN1089370C Recombination vaccinia virus for expression of measles virus L4 strain hemagglutini and fusion protein gene |
| 08/21/2002 | CN1089344C Inhibitor of stem cell proliferation and uses thereof |
| 08/20/2002 | US6437116 Nucleic acid immunogens; lyme disease treatment, diagnosis, and vaccines |
| 08/20/2002 | US6437096 Diagnosing infections; vaccines; genetic engineering and expression |
| 08/20/2002 | US6437095 Method for producing chimeric polypeptides |
| 08/20/2002 | US6436898 Fusion protein having specified amino acid sequence |
| 08/20/2002 | US6436691 Chemical compounds |
| 08/20/2002 | US6436670 Gene and uses therefor |
| 08/20/2002 | US6436652 Method of detecting a pathogen using a virus |
| 08/20/2002 | US6436648 Chimeric viral proteins |
| 08/20/2002 | US6436642 Method of classifying a thyroid carcinoma using differential gene expression |
| 08/20/2002 | US6436629 Modulating angiogenesis |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436408 Cold -adapted equine influenza viruses |
| 08/20/2002 | US6436407 E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity |
| 08/20/2002 | US6436405 Haemophilis influenzae vaccine |
| 08/20/2002 | US6436404 Antitumor |
| 08/20/2002 | US6436403 Pharmaceutical composition of the intercellular adhesion molecule ICAM-1 for use in anti-viral prophylactic therapy |
| 08/20/2002 | US6436402 Process for making human papillomavirus virus-like particles with improved properties |
| 08/20/2002 | US6436401 Administering the combination of anti-glutamic acid decarboxylase (anti-gad) antibody and anti-insulin antibody in amount effective to treat or prevent diabetes |
| 08/20/2002 | US6436391 Use of interferon (IFN)-α8 and -α14 as vaccine adjuvants |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2110055C T cell receptor peptides as therapeutics for immune-related disease |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/20/2002 | CA2063886C Polyethylene protein conjugates |
| 08/20/2002 | CA2006865C Humanized immunoglobulins and their production and use |
| 08/20/2002 | CA1341384C Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav |
| 08/15/2002 | WO2002063012A2 Ragweed allergens |
| 08/15/2002 | WO2002063010A2 Method of producing recombinant antibodies against tumors |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063007A2 TIMM8b-RELATED PROTEIN |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062976A2 Serine proteases |
| 08/15/2002 | WO2002062972A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/15/2002 | WO2002062959A2 Hepatitis b virus treatment |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062851A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | WO2002062847A2 Superficial zone protein and methods of making and using same |
| 08/15/2002 | WO2002062846A2 Method and apparatus for the production of antigens and uses thereof |
| 08/15/2002 | WO2002062845A2 Adhesion molecules |
| 08/15/2002 | WO2002062841A2 Secreted proteins |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062834A2 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | WO2002062777A2 Amino ceramide-like compounds and therapeutic methods of use |
| 08/15/2002 | WO2002062383A2 Antagonists of myelin-associated glycoprotein and their use in the treatment and/or prevention of neurological diseases |
| 08/15/2002 | WO2002062382A1 Inactive bovine scours vaccines, processes and method of preventing bovine scours |
| 08/15/2002 | WO2002062381A1 Baculovirus vector vaccine |
| 08/15/2002 | WO2002062380A2 Chlamydia vaccine composition |
| 08/15/2002 | WO2002062379A2 Clostridium difficile vaccine |
| 08/15/2002 | WO2002062378A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | WO2002062370A2 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 08/15/2002 | WO2002062368A2 Method of inducing a ctl response |
| 08/15/2002 | WO2002062319A2 Microsphere delivery of mucin peptides |
| 08/15/2002 | WO2002062298A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | WO2002062203A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/15/2002 | WO2002062197A2 Markers for disease susceptibility and targets for therapy |
| 08/15/2002 | WO2002051871A3 Anti-cd28 antibody |
| 08/15/2002 | WO2002024734A3 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nuclei c acid |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 08/15/2002 | WO2002020732A3 Regulation of human map kinase phosphatase-like enzyme |
| 08/15/2002 | WO2002014870A3 Use of antibodies against specific mhc-peptide complexes |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002011757A3 Compositions and methods for inhibiting transmission of malaria |
| 08/15/2002 | WO2002008261A3 Bstp-trans protein and related reagents and methods of use thereof |
| 08/15/2002 | WO2002006303A3 Dna vaccines encoding hiv accessory proteins |
| 08/15/2002 | WO2001092321A3 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 08/15/2002 | WO2001087270B1 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001040309A9 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034192A9 Improved method of immunization |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |